Papp L Roy & Associates Abbott Laboratories Transaction History

Papp L Roy & Associates

$820 Million
Q3 2024

A detailed history of Papp L Roy & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Papp L Roy & Associates holds 8,478 shares of ABT stock, worth $960,472. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,478

Previous 8,928 5.04%

Holding current value

$960,472

Previous $927,000 4.21%

% of portfolio

0.12%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $45,031 - $53,158	-450 Reduced 5.04%	8,478 $966,000
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $34,827 - $38,465	-318 Reduced 3.44%	8,928 $1.01 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $4,329 - $5,299	-48 Reduced 0.52%	9,246 $1.02 Million
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $26,748 - $32,093	-280 Reduced 2.92%	9,294 $900,000
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $10,581 - $11,790	-105 Reduced 1.08%	9,574 $1.04 Million
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $15,497 - $18,241	-160 Reduced 1.63%	9,679 $980,000
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $16,943 - $20,479	166 Added 1.72%	9,839 $1.07 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $3,234 - $3,960	-28 Reduced 0.29%	9,673 $1.36 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $46,664 - $51,624	-400 Reduced 3.96%	9,701 $1.15 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $264,580 - $311,449	2,501 Added 32.91%	10,101 $1.17 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $339,907 - $400,462	-3,123 Reduced 29.12%	7,600 $911,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $3,570 - $3,890	34 Added 0.32%	10,723 $1.17 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $76 - $98	1 Added 0.01%	10,689 $977,000
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $2,764 - $4,041	-44 Reduced 0.41%	10,688 $843,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $41,060 - $45,710	-523 Reduced 4.65%	10,732 $932,000
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $12,276 - $13,311	-150 Reduced 1.32%	11,255 $942,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $115,150 - $134,300	1,580 Added 16.08%	11,405 $959,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $48,252 - $54,662	736 Added 8.1%	9,825 $711,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $7,783 - $9,390	-128 Reduced 1.39%	9,089 $667,000
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $53 - $57	1 Added 0.01%	9,217 $526,000
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $442,920 - $494,346	9,216	9,216 $492,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Abbott Laboratories Transaction History